ArticleJournal of market access & health policy2018

Cost-effectiveness of solifenacin compared with oral antimuscarinic agents for the treatment of patients with overactive bladder in the UK.

Zalmai Hakimi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.